000 01814cam a2200325 a 4500
003 EG-GiCUC
008 131225s2013 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.11.07.M.Sc.2013.Ra.S
100 0 _aRaghda Taha Ahmed Mohammad Fouda
245 1 4 _aThe specific von willebrand factor-cleaving protease ADAMTS13 activity in childhood HUS in a Pediatric University Hospital in Egypt /
_cRaghda Taha Ahmed Mohammad Fouda ; Supervised Azza Ahmed Aboulenein , Mohamed Hesham Safouh , Dalia Gameel Amin
246 1 5 _aفى مستشفى طب الأطفال الجامعى فى مصر HUS فى الاطفال المصابون بمرض ال ADAMTS13 دراسة نشاط إنزيم ال
260 _aCairo :
_bRaghda Taha Ahmed Mohammad Fouda ,
_c2013
300 _a185 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
520 _aConsidering the overlapping clinical manifestation of hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP), we hypothesized that ADAMTS13 would be an important factor in discrimination between the two TMAs. The goal of this study was to determine ADAMTS13 activity as well as the presence of inhibitors in children with typical postdiarrheal (D+) or atypical non-post diarrheal (D-) HUS
530 _aIssued also as CD
653 4 _aADAMTS13
653 4 _aChildren
653 4 _aHemolytic uremic syndrome
700 0 _aAzza Ahmed Aboulenein ,
_eSupervisor
700 0 _aDalia Gameel Amin ,
_eSupervisor
700 0 _aMohamed Hesham Safouh ,
_eSupervisor
905 _aNazla
_eRevisor
905 _aSamia
_eCataloger
942 _2ddc
_cTH
999 _c44603
_d44603